Related Experiment Videos
Evaluating limited specificity of drug pumps reduced relative resistance in human MDR phenotypes
A P Jongsma1, A Riethorst, J Lankelma
1Division of Molecular Biology, the Netherlands Cancer Institute, Amsterdam.
Abstract:
In the parallel paper, we developed a property to characterize drug efflux pumps, i.e. the reduced relative resistance (RRR). Using this RRR, we here investigate whether the observed diversity in human multidrug resistance (MDR) phenotypes might be due to variable levels of P-glycoprotein encoded by MDR1. We analyzed resistance phenotypes of various human cell lines in which either one, or both, classical human multidrug resistance genes, MDR1 and MDR3, are overexpressed. In addition, RRR values were calculated for MDR phenotypes presented in the literature. The results suggest that more than a single mechanism is required to account for the observed phenotypic diversity of classical multidrug resistance. This diversity is only partly due to differences in plasma membrane permeabilities between cell line families. It is discussed whether the alternative MDR phenotypes might be MDR1 phenotypes modified by other factors that do not themselves cause MDR. The method we here apply may also be useful for other nonspecific enzymes or pumps.
Insights
Drug efflux pumps influence multidrug resistance (MDR). This study uses reduced relative resistance (RRR) to explore if varying P-glycoprotein levels explain diverse MDR phenotypes, finding other factors are also involved.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) in humans is a complex phenomenon.
- P-glycoprotein, encoded by the MDR1 gene, is a key drug efflux pump implicated in MDR.
- Previous work introduced reduced relative resistance (RRR) to characterize drug efflux pumps.
Purpose of the Study:
- To investigate if variable levels of P-glycoprotein contribute to the diversity of human MDR phenotypes.
- To analyze MDR phenotypes in cell lines with differential expression of MDR1 and MDR3 genes.
- To assess the applicability of the RRR method to literature-reported MDR phenotypes.
Main Methods:
- Analysis of drug resistance phenotypes in human cell lines overexpressing MDR1 and/or MDR3.
- Calculation of reduced relative resistance (RRR) values for experimental and literature data.
- Comparative analysis of RRR values across different cell lines and phenotypes.
Main Results:
- The study found that variable P-glycoprotein levels only partially explain the observed diversity in MDR phenotypes.
- Differences in plasma membrane permeability between cell line families contribute to phenotypic variation.
- Results suggest that mechanisms beyond P-glycoprotein expression are necessary to account for classical MDR diversity.
Conclusions:
- The phenotypic diversity of classical multidrug resistance is multifactorial, not solely due to MDR1/P-glycoprotein levels.
- Alternative MDR phenotypes may arise from MDR1 activity modulated by other cellular factors.
- The RRR methodology shows potential for characterizing other nonspecific enzymes or pumps.